|
|
|
|
| LEADER |
01810cam a22004457a 4500 |
| 001 |
MUB01000880690 |
| 003 |
CZ BrMU |
| 005 |
20220629130058.0 |
| 008 |
131205s2000 sz ||||| |||||||||||eng d |
| STA |
|
|
|a POSLANO DO SKCR
|b 2023-07-14
|
| 020 |
|
|
|a 3-7643-5959-5
|q (alk. paper)
|
| 040 |
|
|
|a BOD002
|b cze
|d BOD114
|
| 072 |
|
7 |
|a 615
|x Farmacie. Farmakologie
|2 Konspekt
|9 14
|
| 080 |
|
|
|a 615.277.3
|2 MRF
|
| 245 |
0 |
0 |
|a Methotrexate /
|c edited by B.N. Cronstein and J.R. Bertino
|
| 260 |
|
|
|a Basel :
|b Springer,
|c c2000
|
| 300 |
|
|
|a 139 s.
|
| 490 |
1 |
|
|a Milestones in drug therapy
|
| 504 |
|
|
|a Obsahuje bibliografii a rejstřík
|
| 650 |
0 |
7 |
|a cytostatické látky
|2 czmesh
|
| 650 |
0 |
7 |
|a methotrexát
|x farmakologie
|2 czmesh
|
| 650 |
0 |
7 |
|a methotrexát
|x terapeutické zžité
|2 czmesh
|
| 650 |
1 |
2 |
|a Methotrexate
|x pharmacology.
|
| 650 |
1 |
2 |
|a Methotrexate
|x therapeutic use.
|
| 650 |
2 |
2 |
|a Antimetabolites, Antineoplastic.
|
| 650 |
2 |
2 |
|a Neoplasms
|x drug therapy.
|
| 700 |
1 |
|
|a Cronstein, Bruce N.
|4 edt
|
| 700 |
1 |
|
|a Bertino, Joseph R.,
|d 1930-
|7 xx0114065
|4 edt
|
| 830 |
|
0 |
|a Milestones in drug therapy
|
| CAT |
|
|
|a GREGROVA
|b 02
|c 20131205
|l MUB01
|h 1008
|
| CAT |
|
|
|c 20150404
|l MUB01
|h 0812
|
| CAT |
|
|
|a BATCH
|b 00
|c 20151226
|l MUB01
|h 0427
|
| CAT |
|
|
|c 20210614
|l MUB01
|h 1007
|
| CAT |
|
|
|c 20210614
|l MUB01
|h 1955
|
| CAT |
|
|
|a HANAV
|b 02
|c 20220629
|l MUB01
|h 1300
|
| CAT |
|
|
|c 20230714
|l MUB01
|h 1123
|
| LOW |
|
|
|a POSLANO DO SKCR
|b 2023-07-14
|
| 994 |
- |
1 |
|l MUB01
|l MUB01
|m BOOK
|1 KUK
|a Knihovna univ. kampusu
|2 KDO
|b Klinika dětské onkologie
|6 3147059995
|5 3147059995
|4 zak. IGA 3232 (patří Klinice dětské onkologie)
|7 Deponováno: Experimentální biologie PřF MU
|8 20131205
|f 78
|f Mimo UK
|g 2013-2561
|r 20131205
|s grant
|
| AVA |
|
|
|a MED50
|b KUK
|c Klinika dětské onkologie
|e available
|t K dispozici
|f 1
|g 0
|h N
|i 0
|j KDO
|
